en
Scientific article
English

Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes

Published inJournal of diabetes & metabolism, vol. 2, no. 4
Publication date2011
Citation (ISO format)
FOUQUERAY, Pascale et al. Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes. In: Journal of diabetes & metabolism, 2011, vol. 2, n° 4. doi: 10.4172/2155-6156.1000126
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2155-6156
811views
1downloads

Technical informations

Creation02/26/2015 3:59:00 PM
First validation02/26/2015 3:59:00 PM
Update time03/14/2023 10:55:56 PM
Status update03/14/2023 10:55:56 PM
Last indexation08/29/2023 3:01:05 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack